CCND3 and neoplasm: Moreover, variable degrees of intra-patient tumor diversity were observed, except in P46 epithelial CTCs which harbored recurrent altered regions such as chromosome 2 (ALK and MYCN gains), chromosome 6 (CCND3 gain), and chromosome 17 (SEPT9 gain).